Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Avenanthramides are a group of low molecular weight phenolic alkaloids found almost exclusively in oats (*Avena sativa*), where they act as phytoalexins (plant defense molecules) against pathogens. Over 40 types of avenanthramides have been identified, with Avn-A, Avn-B, and Avn-C most abundant. They possess strong antioxidant, anti-inflammatory, anti-itch, and skin-soothing properties, making them leading actives in topical and dermatological formulations. Their bioactivity is demonstrated in reduction of oxidative stress and modulation of inflammatory pathways—effects attributed to their ability to scavenge reactive oxygen species and downregulate inflammatory cytokine expression[5][1][2][3]. They are used in formulations derived from oat extracts, flour, and oil, and confer benefits ranging from allergy and irritation reduction to possible cardiovascular and neuroprotective effects.
Scavenging of reactive oxygen species (antioxidant action); Inhibition of pro-inflammatory cytokines (modulates immune response); Inhibition of histamine release and activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Avenanthramide (Avn (sometimes used in the literature, but not a universal abbreviation)).